NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA ANALYTICAL DEVELOPMENT
MONTHLY REPORT & PLAN: JANUARY 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA ANALYTICAL DEVELOPMENT
Monthly Report December 2021
Nuvista Analytical Development Department
Assay Method Development
SI. No.
01
Activity
Mucopolysaccharide Polysulphate
(MPS) 0.2% + Salicylic Acid 2% Gel
TOTAL DONE : 0
Status
Done
Not
Done
Pending
due to
Supplier
method
Done By
Pending
30.01.22
TOTAL Running : 1
Dissolution Method Development
01
Ferric Maltol Capsule
TOTAL DONE : 0
Running
30.01.22
TOTAL Running : 1
Assay Method Validation Protocol Preparation
01
02
03
Testerone Injection
Done
Shakhawat
Dequalinium Chloride Tablet
Done
Safiqul
Islam
Deaca Duraboline injection
Running
30.01.22
Total Done : 02
Total Running : 1
Assay Method Validation Work and Report Preparation
01
Obetacholic acid 5 & 15 mg Tablet
TOTAL DONE : 01
Done
TOTAL PENDING : 0
Shakhawat
NAD Monthly Report: December 2021
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
STP Preparation & Approval
01
Ferric Maltol Capsule
Running
30.01.22
02
Ferric Derisomaltose injection
Running
30.01.22
03
Calcium Folinate 5 & 15 mg tablet
Running
30.01.22
04
Caprogen DS injection
Running
30.01.22
05
Ulipristal acetate 30 mg tablet
Running
30.01.22
06
Elagolix 200 mg tablet
Running
30.01.22
Total done : 06
Total pending: 6
3 Month Stability Data Preparation
01
Ulipristal acetate 30 mg tablet
TOTAL DONE : 1
Running
20.01.22
TOTAL PENDING : 0
6 Month Stability Data Preparation
01
Dekalin VT
Done
02
Folinic Acid 5 mg Tablet
Running
20.01.22
03
Folinic Acid 5 mg Tablet
Running
20.01.22
TOTAL DONE : 1
TOTAL PENDING : 2
Stability Sample Analysis (Initial)
01
Cyproterone acetate 50 mg Tablet
TOTAL DONE : 1
Done
Rukhsana
TOTAL PENDING : 0
NAD Monthly Report: December 2021
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
Stability Sample Analysis (1M Stability Test)
01
Pending
Ferric Maltol 30 mg Iron Capsule
TOTAL DONE : 0
30.01.22
TOTAL PENDING : 1
Stability Sample Analysis (3M Stability Test)
01
Ulipristal acetate 30 mg Tablet
Running
TOTAL DONE : 01
20.01.22
TOTAL PENDING : 0
Stability Sample Analysis (6M Stability Test)
01
Folinic Acid 15 mg Tablet
Done
Rukhsana
02
Folinic Acid 5 mg Tablet
Done
Rukhsana
03
Roxadex 6 mg Tablet
Done
Rukhsana
Total Done : 03
Total Pending : 0
SOP Preparation & Approval:
Sop Name
Done by
01
Water Purification system
Under Preparation
30.01.22
02
Glassware management SOP
Under Preparation
30.01.22
Done
NDQ
Done
NDQ
03
04
Preparation & recording of analytical
lab note book
Preparation & review of analytical
method verification / validation
protocol
Total Done : 02
Total Pending: 02
NAD Monthly Report: December 2021
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
New Product Technology Transfer
DONE BY:
Product/material name:
01
Done
N/A
N/A
DTL Sample Submission
Product/Material Name:
DTL Test
Done by:
Obeticholic acid 5 & 10 mg tablet
Safiqul Islam
Raw Materials Test
Material Name
Source Material
Test
Responsible Person
Lactic Acid
Done
Safiqul Islam
Citric Acid
Done
Safiqul Islam
Potassium Biterterate
Done
Safiqul Islam
Calcium Folinate
Done
Safiqul Islam
Feric maltol
Done
Safiqul Islam
Total Test Done:
04 Materials
Raw Materials Received
Sorbitan Monooleate
Received
Safiqul Islam
White Soft Paraffin BP
Received
Safiqul Islam
Liquid Paraffin BP
Received
Safiqul Islam
NAD Monthly Report: December 2021
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
Mirogabalin Besylate
Received
Safiqul Islam
Relugolix
Received
Safiqul Islam
Ozenoxacin
Received
Safiqul Islam
Lanoline Anhydrous EP
Received
Safiqul Islam
Eflornithine Hydrochloride Monohydrate
Received
Safiqul Islam
Macrogol 3350
Received
Safiqul Islam
Ceto Steryl Alcohol
Received
Safiqul Islam
Estradiol USP Micronized
Received
Safiqul Islam
Total Material Received
11 Materials
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA ANALYTICAL DEVELOPMENT
Monthly Plan January 2022
Nuvista Analytical Development Department
Assay Method Development
Sr. No.
01
Particulars
Status
Mucopolysaccharide Polysulphate (MPS)
0.2% + Salicylic Acid 2% Gel
Running
Dissolution Method Development
01
Ferric Maltol Capsule
Running
Assay Method Validation Protocol Preparation
01
Deaca Duraboline injection
Running
02
Elagolix 200 mg tablet
Running
03
Ulipristal acetate 30mg tablet
Running
Assay Method Validation Work and Report Preparation
01
Dekalin VT tablet
Running
02
Testanone injection
Running
03
Elagolix 200 mg tablet
Running
04
Ulipristal acetate 30mg tablet
STP Preparation & Approval
01
Ferric Maltol Capsule
Running
02
Ferric Derisomaltose injection
Running
Remarks
NAD Monthly Plan: January 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
03
Calcium Folinate 5 & 15 mg tablet
Running
04
Caprogen DS injection
Running
05
Ulipristal acetate 30 mg tablet
Running
06
Elagolix 200 mg tablet
Running
07
Deaca Duraboline injection
Running
Comparative Dissolution Analysis
01
Doxavit 10 DR Tablet
Done
3 Month Stability Data Preparation
Sr. No.
Particulars
Status
01
Thyronor 12.5 mcg tablet
Running
02
Calcium Dobesilate 500 mg Capsule
Running
03
Ferric maltose 30 mg iron Capsule
Running
04
Ferric derisomaltose 100 mg/ml injection
Running
6 Month Stability Data Preparation
01
Elagolix 150 mg Tablet
Running
02
Delanzo 30 Capsule
Running
Stability Sample Analysis (Initial)
01
Cyproterone acetate 50 mg tablet
Running
Remarks
NAD Monthly Plan: January 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
02
Clascoterone INN 1% Cream
Running
03
Abametapir INN 0.74% Lotion
Running
04
Mucopolysaccharide Polysulphate (MPS)
0.2% + Salicylic Acid 2% Gel
Running
05
Thyronor 50 , 75 & 100 mcg tablet
Running
Stability Sample Analysis (1 Month)
01
LA, CA & PBT Gel
Running
02
(MPS) 0.2% + Salicylic Acid 2% Gel
Running
Stability Sample Analysis (3 Month)
01
Thyronor 12.5 mcg tablet
Running
02
Calcium Dobesilate 500 mg Capsule
Running
03
Ferric maltose 30 mg iron Capsule
Running
04
Ferric derisomaltose 100 mg/ml injection
Running
Stability Sample Analysis (6 Months)
01
Delanzo 30 Capsule
Running
02
Elagolix 150 mg Tablet
Running
SOP Preparation & Approval:
01
Water Purification system
Running
02
Handling, washing and calibration of
Glassware
Running
Due because of machine
under installation
NAD Monthly Plan: January 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
03
Operation, cleaning and calibration
procedure for Micropipette
Running
Raw Materials Test
Product/Material Name
Done by
QC Selected
1
Carbopol 980 NF Polymer
Running
2
Glycerine BP
Running
3
Lipoid SPE-3
Running
4
Hydroxy Propyl Betadex
Running
5
Kolliphor HS 15
Running
6
Lansoprazole WS
Running
7
Sorbitan Monooleate
Running
8
White Soft Paraffin BP
Running
9
Liquid Paraffin BP
Running
10
Mirogabalin Besylate
Running
11
Relugolix
Running
12
Ozenoxacin
Running
13
Lanoline Anhydrous EP
Running
14
Eflornithine Hydrochloride Monohydrate
Running
NAD Monthly Plan: January 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
15
Macrogol 3350
Running
16
Ceto Steryl Alcohol
Running
17
Estradiol USP Micronized
Running
New Product Technology Transfer
N/A
DTL Sample Preparation
Product Name
Done by
Elagolix 200 mg Tablet
To be Submit at DTL by this month
Obeticholic Acid 5 & 10 mg tablet
Done
NAD Monthly Plan: January 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
List of Expired Standard[Next 3 Month]
Impurity
Sr.
No.
Name of Impurity
Batch Number
01
Elagolix Sodium
OTF-V Impurity/A044/11
19/155/376OTF-I/A044/12
19/155/388
02
Ethinyl Estradiol Related
Compound B
R068F0
Amount
Expiry Date
20 mg
20 mg
20 mg
20 mg
20.08.22
20 mg
28-FEB-2022
RS/CRS
Sr.
No.
Name of RS/CRS
Batch No./ Lot No.
Amount (mg)
Expiry Date
01
Cabergoline USP
F0H240
125
Current
02
Estradiol USP
R025F0
500
Current
03
Estrone
R030H0
200
31-JAN-2022
04
Drospirenone
R04250
200
31-JAN-2022
05
Progesterone
I2J239
200
Current
06
Hydroxyprogesterone
Caproate
R058T0
200
31-MAY-2021
07
Estradiol Valerate
M0M467
100
30-JUN-2021
08
Desogestrel
R04270
200
Current
09
Lansoprazole
I0M366
150
31-AUG-2022
10
Citric Acid
R062M0
400
Current
11
Eflornithine Hydrochloride
R06840
150
30-SEP-2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA ANALYTICAL DEVELOPMENT
Monthly Report December 2021
Nuvista Product Development Department
Formulation Development Trial
SI.
No.
Status
Activity
Done
Not
Done
Pending
Remarks/
Target Date
01
Nomegestrol acetate 2.5 mg plus
Estradiol 1.5mg Tablet
Running
By 25th January
02
Ferric Derisomaltose Injection 10 ml
Running
By 25th January
03
Crisaborole 2% Ointment
Running
By 15th January
04
Estriol 0.01% w/w Cream
Running
By 25th January
05
Eflrnithine HCl 11.5% Cream
Running
By 25th January
06
Magnesium Aspartate Dihydrate PFS
Running
By 25th January
07
Thyronor 50, 75 & 100 mcg Tablet
Done
TOTAL DONE: 01 Products
TOTAL Running: 06 Products
Stability Trial & Protocol Preparation
01
Clascoterone INN 1% Cream
Done
Under Stability
02
Abametapir INN 0.74% Lotion
Running
Waiting for PM
Done
Under Stability &
SSP done by 10th Jan
Done
Under Stability
Done
Yet to Start the
stability
03
04
05
Mucopolysaccharide Polysulphate
(MPS) 0.2% + Salicylic Acid 2% Gel
Lactic acid USP 18mg, CA USP 10mg
and PBT USP 4 mg Gel
Ciproterone Acetate 50 mg Tablet
TOTAL DONE: 04 Products
TOTAL Running: 01 Product
NPD Monthly Report: December 2021
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
Product Data Sheet Preparation
01
02
Mucopolysaccharide Polysulphate
(MPS) 0.2% + Salicylic Acid 2% Gel
Lactic acid USP 18mg, CA USP 10mg
and PBT USP 4 mg Gel
Done
Draft Data Sheet
Done
Draft Data Sheet
03
Clascoterone INN 1% Cream
Done
Draft Data Sheet
04
Abametapir INN 0.74% Lotion
Done
Draft Data Sheet
05
Ciproterone Acetate 50 mg Tablet
Done
Draft Data Sheet
06
Femipil Tablet
Done
Final Data Sheet
07
Dekalin VT
Done
Final Data Sheet
TOTAL DONE : 07 Products
TOTAL Running : 00 Product
Recipe Preparation
01
Water For Injection
Total Done : 01 Product
Done
Waiting for
Approval
TOTAL PENDING : 00 Products
Material Requisition(Resource)
MI/PI Preparation
01
Deflazacort Tablet
Done
02
Adam 20 Tablet
Done
TOTAL DONE : 00 Products
TOTAL PENDING : 00 Products
PDR Preparation
01
Caprogen Injection
Done
02
Roxadex Injection
Done
03
Traxyl Capsule
Running
Done By 25th January
04
Carbeshot Injection
Running
Done By 25th January
05
Tibilon Tablet
Running
Done By 25th January
NPD Monthly Report: December 2021
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
06
Norestin Tab.
Running
Done By 25th January
07
Testanon Injection
Running
Done By 25th January
Total Done : 02 Products
Total Pending : 05 Products
Sop Preparation
Total Done : 00 SOPs
Total Pending : 00 Sops
BMR & BPR Preparation
01
Linaclotide Capsule
Running
Done By 25th January
02
Calcium Dobesilate Capsule
Running
Done By 25th January
03
Dekalin VT
Done
04
Hipomax Tablet
Done
05
Magnox Tablet
Running
Total Done : 02 Products
Done By 15th January
Total Pending : 03 Products
Annexure Preparation/Amendment
Calcium Dobesilate 500 Capsule (Hemroid For New Inclusion
Capsule )
TOTAL DONE : 01 Products
Total Pending : 00 Products
Commercial Batch Manufacturing
Product Name/No of Batch
Current Status
Elagox Tablet
Third Batch Manufacturing Done
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA ANALYTICAL DEVELOPMENT
Monthly Plan January 2022
Nuvista Product Development Department
Formulation Development Trial
SI.
No.
Activity
Status
Done
Not Done
Done By/Remarks
Pending
01
Nomegestrol acetate 2.5 mg plus
Estradiol 1.5mg Tablet
Running
Done By 25th January
02
Ferric Derisomaltose Injection 10
ml
Running
Done By 25th January
03
Crisaborole 2% Ointment
Running
Done By 15th January
04
Estriol 0.01% w/w Cream
Running
Done By 25th January
05
Eflrnithine HCl 11.5% Cream
Running
Done By 25th January
06
Magnesium Aspartate Dihydrate
PFS
Running
Done By 25th January
07
Ciclopirox Lotion
New
Total Done: 00 Products
Total Running: 00 Product
Stability Trial & Protocol Preparation
01
Clascoterone INN 1% Cream
Done
Two More New trial
required
02
Abametapir INN 0.74% Lotion
Running
Waiting for PM
03
Ciproterone Acetate 50 mg Tablet
Running
Yet to Start the
stability
04
Thyronor 50, 75 & 100 mcg Tablet
Running
Yet to Start the
stability
Total Done: 00 Products
Total Running: 02 Product
NPD Monthly Plan: January 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
Product Data Sheet Preparation
01
Thyronor 25 Tablet
02
Thyronor 75 Tablet
03
Thyronor 100 Tablet
04
Marvelon Tablet
05
Microlon Tablet
06
Elisa Tablet &
4 Placebo
07
Cleo 35 Tablet
08
Thyronor 50 Tablet
09
Ovostat Gold Tablet
Total Done : 00 Products
New
New
New
New
New
New
New
New
New
Total Running: 00 Product
Recipe Preparation
Total Done : 00 Product
Material Requisition(Resource)
MI/PI Preparation
Total Pending : 00 Products
NPD Monthly Plan: January 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
Total Done : 00 Products
Total Pending : 00 Products
PDR Preparation
01
Traxyl Capsule
02
Carbeshot Injection
03
Tibilon Tablet
04
Norestin Tab.
05
Testanon Injection
Total Done : 00 Products
Running
Done By 25th Dec
Running
Done By 25th Dec
Running
Done By 25th Dec
Running
Done By 25th Dec
Running
Done By 25th Dec
Total Pending : 00 Products
SOP Preparation
Total Done : 00 SOPs
Total Pending : 00 SOPs
BMR & BPR Preparation
01
Osmifen Tablet
New
Sumon Kumar Datta
02
Linaclotide Capsule
Running
Done By 20th January
03
Calcium Dobesilate Capsule
Running
Done By 20th January
04
Dekalin VT
Done
Sumon Kumar Datta
05
Elagox Tablet
New
Sumon Kumar Datta
Total Done : 01 Products
Total Pending : 04 Products
NPD Monthly Plan: January 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
Annexure Preparation/Amendment
01
Calcium Folinate 5 mg Tablet
Done
Submitted
02
Calcium Folinate 15 mg Tablet
Done
Submitted
TOTAL DONE : 00 Products
TOTAL PENDING: 00 Products
Commercial Batch Manufacturing
Product Name/No of Batch
Current Status
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA ANALYTICAL DEVELOPMENT
Monthly Plan & Report January 2022
Nuvista Development Quality Department
SOP Preparation & Distribution
SI.
No.
01
02
03
04
05
06
07
08
09
Status
List of SOP on
Preparation & Recording of Analytical
Lab Note Book
Preparation & Review of Analytical
Method Verification / Validation
Protocol
Operation, temperature mapping &
maintenance of Arctiko Refrigerator
(model no.: pr1400)
Waste Management of Product
Development Department
Setup, Operation, Cleaning &
Calibration of Newtronic Stability
Chamber (30°C ± 2°C & 65% ± 5% RH)
Setup, Operation, Cleaning &
Calibration Of Newtronic Stability
Chamber (40°C ± 2°C & 75% ± 5% RH)
Set Up, Operation, Cleaning And
Calibration Of Thermolab Photostability
Chamber
Handling, washing and calibration of
Glassware
operation, cleaning and calibration
procedure for micropipette
Done
Not
Done
Pending
Remarks/
Target Date
Done
Done
Under
Review
10.01.22
Under
Review
20.01.22
Under
Review
25.01.22
Under
Review
30.01.22
New
SOP
30.01.22
New
SOP
30.01.22
New
SOP
30.01.22
NDQ Monthly Plan & Report: January 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
Annexure Amendment Activities
SI.
No.
List of Product
Done
01
Anaroxyl Injection
Done
02
Carbeshot Injection
Done
03
Deca -Durabolin Injection
Done
04
Durabolin Injection
Done
05
Ketoshot 30 Injection
Done
06
Linda-S Ds Injection
Done
07
Ofmit Tablet
Done
08
Roxadex 5 Injection
Done
09
Testanon Injection
Done
10
Visceralgine Injection
Done
Status
Not
Done
Pending
Remarks/
Target
Date
NDQ Monthly Plan & Report: January 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
Pending calibration report status
SI.
No.
01
02
03
04
05
06
07
08
09
10
Status
Name of the Instruments/Equipment’s
No pending, all done on due date.
Done
Not
Done
Pending
Remarks/
Target Date
NDQ Monthly Plan & Report: January 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
Calibration Schedule[Next 2 Month]
SI.
No.
Status
Name of the Instruments/Equipment’s
Remarks
Due date
Responsibility
01
Hardness Tester
23-01-22
Khan & Deen
External
02
Electrolab Dissolution Tester
11-02-22
SAKA Int’l Ltd.
External
03
Electrolab Disintegration Tester
04-02-22
In House
Internal
04
05
06
07
08
09
10
NDQ Monthly Plan & Report: January 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
NAD Logbook Status [Total Working Days: 23]
SI.
No.
Status
Name of the Instruments/Equipment’s
Done
Not
Done
Pending
Total Used
(Days)
01
HPLC- Prominence I plus
[ID: PDT/E/028]
OK
--
--
12 Days
02
HPLC- Prominence I plus
[ID: PDT/E/029]
OK
--
--
14 Days
03
HPLC- Prominence I
[ID: PDT/E/014]
OK
--
--
16 Days
04
05
06
07
08
09
10
NDQ Monthly Plan & Report: January 2022
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
Leave Status
Employee Name
Privilege Leave
Sick Leave
Last Month
Provided
Avail
Provided
Avail
Privilege
Leave
Sick
Leave
Sumon Kumar Datta
20
6.5
14
2
0.5
0
Rukhsana Nazneen
20
7
14
2
0
1
Md. Aslam Mia
20
2.5
14
0
0.5
0
Md. Shajadur
Rahaman
20
3.5
14
0
0
0
Shakawat Hossain
20
9
14
3
2
0
Roshidul Islam
20
N/A
14
N/A
N/A
N/A
Md. Safiqul Islam
20
4
14
8
0
1
Ramanath Kumar
20
8
14
3
0.5
0
NUVISTA PHARMA LIMITED
PRODUCT DEVELOPMENT
48, TONGI I/A, GAZIPUR, BANGLADESH
NUVISTA PRODUCT DEVELOPMENT
Prepared By
Department
Designation
NDQ, PDT
Asst. Manager, NDQ
Signature & Date
Reviewed By
Department
Designation
NAD, PDT
Asst. Manager, NAD
NPD, PDT
Deputy Manager, NPD
Signature & Date
Approved By
Department
Designation
R&D
General Manager, R&D
Signature & Date